podesta_email_21309.txt

podesta-emails 2,555 words email

V11 P19 V16 P22 D4

-----BEGIN PGP PUBLIC KEY BLOCK----- mQQBBGBjDtIBH6DJa80zDBgR+VqlYGaXu5bEJg9HEgAtJeCLuThdhXfl5Zs32RyB I1QjIlttvngepHQozmglBDmi2FZ4S+wWhZv10bZCoyXPIPwwq6TylwPv8+buxuff B6tYil3VAB9XKGPyPjKrlXn1fz76VMpuTOs7OGYR8xDidw9EHfBvmb+sQyrU1FOW aPHxba5lK6hAo/KYFpTnimsmsz0Cvo1sZAV/EFIkfagiGTL2J/NhINfGPScpj8LB bYelVN/NU4c6Ws1ivWbfcGvqU4lymoJgJo/l9HiV6X2bdVyuB24O3xeyhTnD7laf epykwxODVfAt4qLC3J478MSSmTXS8zMumaQMNR1tUUYtHCJC0xAKbsFukzbfoRDv m2zFCCVxeYHvByxstuzg0SurlPyuiFiy2cENek5+W8Sjt95nEiQ4suBldswpz1Kv n71t7vd7zst49xxExB+tD+vmY7GXIds43Rb05dqksQuo2yCeuCbY5RBiMHX3d4nU 041jHBsv5wY24j0N6bpAsm/s0T0Mt7IO6UaN33I712oPlclTweYTAesW3jDpeQ7A ioi0CMjWZnRpUxorcFmzL/Cc/fPqgAtnAL5GIUuEOqUf8AlKmzsKcnKZ7L2d8mxG QqN16nlAiUuUpchQNMr+tAa1L5S1uK/fu6thVlSSk7KMQyJfVpwLy6068a1WmNj4 yxo9HaSeQNXh3cui+61qb9wlrkwlaiouw9+bpCmR0V8+XpWma/D/TEz9tg5vkfNo eG4t+FUQ7QgrrvIkDNFcRyTUO9cJHB+kcp2NgCcpCwan3wnuzKka9AWFAitpoAwx L6BX0L8kg/LzRPhkQnMOrj/tuu9hZrui4woqURhWLiYi2aZe7WCkuoqR/qMGP6qP EQRcvndTWkQo6K9BdCH4ZjRqcGbY1wFt/qgAxhi+uSo2IWiM1fRI4eRCGifpBtYK Dw44W9uPAu4cgVnAUzESEeW0bft5XXxAqpvyMBIdv3YqfVfOElZdKbteEu4YuOao FLpbk4ajCxO4Fzc9AugJ8iQOAoaekJWA7TjWJ6CbJe8w3thpznP0w6jNG8ZleZ6a jHckyGlx5wzQTRLVT5+wK6edFlxKmSd93jkLWWCbrc0Dsa39OkSTDmZPoZgKGRhp Yc0C4jePYreTGI6p7/H3AFv84o0fjHt5fn4GpT1Xgfg+1X/wmIv7iNQtljCjAqhD 6XN+QiOAYAloAym8lOm9zOoCDv1TSDpmeyeP0rNV95OozsmFAUaKSUcUFBUfq9FL uyr+rJZQw2DPfq2wE75PtOyJiZH7zljCh12fp5yrNx6L7HSqwwuG7vGO4f0ltYOZ dPKzaEhCOO7o108RexdNABEBAAG0Rldpa2lMZWFrcyBFZGl0b3JpYWwgT2ZmaWNl IEhpZ2ggU2VjdXJpdHkgQ29tbXVuaWNhdGlvbiBLZXkgKDIwMjEtMjAyNCmJBDEE EwEKACcFAmBjDtICGwMFCQWjmoAFCwkIBwMFFQoJCAsFFgIDAQACHgECF4AACgkQ nG3NFyg+RUzRbh+eMSKgMYOdoz70u4RKTvev4KyqCAlwji+1RomnW7qsAK+l1s6b ugOhOs8zYv2ZSy6lv5JgWITRZogvB69JP94+Juphol6LIImC9X3P/bcBLw7VCdNA mP0XQ4OlleLZWXUEW9EqR4QyM0RkPMoxXObfRgtGHKIkjZYXyGhUOd7MxRM8DBzN yieFf3CjZNADQnNBk/ZWRdJrpq8J1W0dNKI7IUW2yCyfdgnPAkX/lyIqw4ht5UxF VGrva3PoepPir0TeKP3M0BMxpsxYSVOdwcsnkMzMlQ7TOJlsEdtKQwxjV6a1vH+t k4TpR4aG8fS7ZtGzxcxPylhndiiRVwdYitr5nKeBP69aWH9uLcpIzplXm4DcusUc Bo8KHz+qlIjs03k8hRfqYhUGB96nK6TJ0xS7tN83WUFQXk29fWkXjQSp1Z5dNCcT sWQBTxWxwYyEI8iGErH2xnok3HTyMItdCGEVBBhGOs1uCHX3W3yW2CooWLC/8Pia qgss3V7m4SHSfl4pDeZJcAPiH3Fm00wlGUslVSziatXW3499f2QdSyNDw6Qc+chK hUFflmAaavtpTqXPk+Lzvtw5SSW+iRGmEQICKzD2chpy05mW5v6QUy+G29nchGDD rrfpId2Gy1VoyBx8FAto4+6BOWVijrOj9Boz7098huotDQgNoEnidvVdsqP+P1RR QJekr97idAV28i7iEOLd99d6qI5xRqc3/QsV+y2ZnnyKB10uQNVPLgUkQljqN0wP XmdVer+0X+aeTHUd1d64fcc6M0cpYefNNRCsTsgbnWD+x0rjS9RMo+Uosy41+IxJ 6qIBhNrMK6fEmQoZG3qTRPYYrDoaJdDJERN2E5yLxP2SPI0rWNjMSoPEA/gk5L91 m6bToM/0VkEJNJkpxU5fq5834s3PleW39ZdpI0HpBDGeEypo/t9oGDY3Pd7JrMOF zOTohxTyu4w2Ql7jgs+7KbO9PH0Fx5dTDmDq66jKIkkC7DI0QtMQclnmWWtn14BS KTSZoZekWESVYhORwmPEf32EPiC9t8zDRglXzPGmJAPISSQz+Cc9o1ipoSIkoCCh 2MWoSbn3KFA53vgsYd0vS/+Nw5aUksSleorFns2yFgp/w5Ygv0D007k6u3DqyRLB W5y6tJLvbC1ME7jCBoLW6nFEVxgDo727pqOpMVjGGx5zcEokPIRDMkW/lXjw+fTy c6misESDCAWbgzniG/iyt77Kz711unpOhw5aemI9LpOq17AiIbjzSZYt6b1Aq7Wr aB+C1yws2ivIl9ZYK911A1m69yuUg0DPK+uyL7Z86XC7hI8B0IY1MM/MbmFiDo6H dkfwUckE74sxxeJrFZKkBbkEAQRgYw7SAR+gvktRnaUrj/84Pu0oYVe49nPEcy/7 5Fs6LvAwAj+JcAQPW3uy7D7fuGFEQguasfRrhWY5R87+g5ria6qQT2/Sf19Tpngs d0Dd9DJ1MMTaA1pc5F7PQgoOVKo68fDXfjr76n1NchfCzQbozS1HoM8ys3WnKAw+ Neae9oymp2t9FB3B+To4nsvsOM9KM06ZfBILO9NtzbWhzaAyWwSrMOFFJfpyxZAQ 8VbucNDHkPJjhxuafreC9q2f316RlwdS+XjDggRY6xD77fHtzYea04UWuZidc5zL VpsuZR1nObXOgE+4s8LU5p6fo7jL0CRxvfFnDhSQg2Z617flsdjYAJ2JR4apg3Es G46xWl8xf7t227/0nXaCIMJI7g09FeOOsfCmBaf/ebfiXXnQbK2zCbbDYXbrYgw6 ESkSTt940lHtynnVmQBvZqSXY93MeKjSaQk1VKyobngqaDAIIzHxNCR941McGD7F qHHM2YMTgi6XXaDThNC6u5msI1l/24PPvrxkJxjPSGsNlCbXL2wqaDgrP6LvCP9O uooR9dVRxaZXcKQjeVGxrcRtoTSSyZimfjEercwi9RKHt42O5akPsXaOzeVjmvD9 EB5jrKBe/aAOHgHJEIgJhUNARJ9+dXm7GofpvtN/5RE6qlx11QGvoENHIgawGjGX Jy5oyRBS+e+KHcgVqbmV9bvIXdwiC4BDGxkXtjc75hTaGhnDpu69+Cq016cfsh+0 XaRnHRdh0SZfcYdEqqjn9CTILfNuiEpZm6hYOlrfgYQe1I13rgrnSV+EfVCOLF4L P9ejcf3eCvNhIhEjsBNEUDOFAA6J5+YqZvFYtjk3efpM2jCg6XTLZWaI8kCuADMu yrQxGrM8yIGvBndrlmmljUqlc8/Nq9rcLVFDsVqb9wOZjrCIJ7GEUD6bRuolmRPE SLrpP5mDS+wetdhLn5ME1e9JeVkiSVSFIGsumZTNUaT0a90L4yNj5gBE40dvFplW 7TLeNE/ewDQk5LiIrfWuTUn3CqpjIOXxsZFLjieNgofX1nSeLjy3tnJwuTYQlVJO 3CbqH1k6cOIvE9XShnnuxmiSoav4uZIXnLZFQRT9v8UPIuedp7TO8Vjl0xRTajCL PdTk21e7fYriax62IssYcsbbo5G5auEdPO04H/+v/hxmRsGIr3XYvSi4ZWXKASxy a/jHFu9zEqmy0EBzFzpmSx+FrzpMKPkoU7RbxzMgZwIYEBk66Hh6gxllL0JmWjV0 iqmJMtOERE4NgYgumQT3dTxKuFtywmFxBTe80BhGlfUbjBtiSrULq59np4ztwlRT wDEAVDoZbN57aEXhQ8jjF2RlHtqGXhFMrg9fALHaRQARAQABiQQZBBgBCgAPBQJg Yw7SAhsMBQkFo5qAAAoJEJxtzRcoPkVMdigfoK4oBYoxVoWUBCUekCg/alVGyEHa ekvFmd3LYSKX/WklAY7cAgL/1UlLIFXbq9jpGXJUmLZBkzXkOylF9FIXNNTFAmBM 3TRjfPv91D8EhrHJW0SlECN+riBLtfIQV9Y1BUlQthxFPtB1G1fGrv4XR9Y4TsRj VSo78cNMQY6/89Kc00ip7tdLeFUHtKcJs+5EfDQgagf8pSfF/TWnYZOMN2mAPRRf fh3SkFXeuM7PU/X0B6FJNXefGJbmfJBOXFbaSRnkacTOE9caftRKN1LHBAr8/RPk pc9p6y9RBc/+6rLuLRZpn2W3m3kwzb4scDtHHFXXQBNC1ytrqdwxU7kcaJEPOFfC XIdKfXw9AQll620qPFmVIPH5qfoZzjk4iTH06Yiq7PI4OgDis6bZKHKyyzFisOkh DXiTuuDnzgcu0U4gzL+bkxJ2QRdiyZdKJJMswbm5JDpX6PLsrzPmN314lKIHQx3t NNXkbfHL/PxuoUtWLKg7/I3PNnOgNnDqCgqpHJuhU1AZeIkvewHsYu+urT67tnpJ AK1Z4CgRxpgbYA4YEV1rWVAPHX1u1okcg85rc5FHK8zh46zQY1wzUTWubAcxqp9K 1IqjXDDkMgIX2Z2fOA1plJSwugUCbFjn4sbT0t0YuiEFMPMB42ZCjcCyA1yysfAd DYAmSer1bq47tyTFQwP+2ZnvW/9p3yJ4oYWzwMzadR3T0K4sgXRC2Us9nPL9k2K5 TRwZ07wE2CyMpUv+hZ4ja13A/1ynJZDZGKys+pmBNrO6abxTGohM8LIWjS+YBPIq trxh8jxzgLazKvMGmaA6KaOGwS8vhfPfxZsu2TJaRPrZMa/HpZ2aEHwxXRy4nm9G Kx1eFNJO6Ues5T7KlRtl8gflI5wZCCD/4T5rto3SfG0s0jr3iAVb3NCn9Q73kiph PSwHuRxcm+hWNszjJg3/W+Fr8fdXAh5i0JzMNscuFAQNHgfhLigenq+BpCnZzXya 01kqX24AdoSIbH++vvgE0Bjj6mzuRrH5VJ1Qg9nQ+yMjBWZADljtp3CARUbNkiIg tUJ8IJHCGVwXZBqY4qeJc3h/RiwWM2UIFfBZ+E06QPznmVLSkwvvop3zkr4eYNez cIKUju8vRdW6sxaaxC/GECDlP0Wo6lH0uChpE3NJ1daoXIeymajmYxNt+drz7+pd jMqjDtNA2rgUrjptUgJK8ZLdOQ4WCrPY5pP9ZXAO7+mK7S3u9CTywSJmQpypd8hv 8Bu8jKZdoxOJXxj8CphK951eNOLYxTOxBUNB8J2lgKbmLIyPvBvbS1l1lCM5oHlw WXGlp70pspj3kaX4mOiFaWMKHhOLb+er8yh8jspM184= =5a6T -----END PGP PUBLIC KEY BLOCK----- To ensure delivery, please add [email protected] ( mailto:[email protected] ) to your address book or contacts. October 15, 2015 WEBSITE ( http://www.geneticsandsociety.rsvp1.com/s182cel93kZp ) BLOG ( http://www.biopoliticaltimes.rsvp1.com/s1420fl93kZq ) ABOUT US ( http://www.geneticsandsociety.rsvp1.com/s1434fl93kZr ) PRESS ROOM ( http://www.geneticsandsociety.rsvp1.com/s1838el93kZs ) DONATE ( https://networkforgood.rsvp1.com/s141cfl93kZt ) SUBSCRIBE ( http://www.geneticsandsociety.rsvp1.com/s1810el93kZu ) Please also follow us on Twitter ( http://twitter.rsvp1.com/s1804el93kZv ), Facebook ( http://www.facebook.rsvp1.com/s1408fl93kZw ), YouTube ( http://www.youtube.rsvp1.com/s144cfl93kZx ), Google+ ( https://google.rsvp1.com/s1840el93kZy ), RSS ( http://www.geneticsandsociety.rsvp1.com/s1854el93kZz ) and on our website ( http://www.geneticsandsociety.rsvp1.com/s1560fl93kZA ) and blog ( http://www.biopoliticaltimes.rsvp1.com/s1574fl93kZB ). Talking Biopolitics with Robert Wilson and Milton Reynolds ( http://www.geneticsandsociety.rsvp1.com/s1978el93kZC ) Thursday, November 19 - 11am PT / 2pm ET / 18:00 GMT In this Talking Biopolitics ( http://www.geneticsandsociety.rsvp1.com/s155cfl93kZD )conversation, University of Alberta filmmaker Robert Wilson will be interviewed by Milton Reynolds from Facing History and Ourselves about this just-release documentary, Surviving Eugenics. ( http://www.geneticsandsociety.rsvp1.com/s1950el93kZE ) Talking Biopolitics on YouTube: George Annas interviewed by Lisa Ikemoto on Genomic Messages ( https://youtu.rsvp1.com/s1944el93kZF ) In case you missed the intellectually and politically stimulating conversation about George Annas's new book Genomic Messages: How the Evolving Science of Genetics Affects Our Health, Families, and Future, it's now online here ( https://youtu.rsvp1.com/s1548fl93kZG ). San Francisco Bay Area events Surviving Eugenics: Next up ( https://facebook.rsvp1.com/s150cfl93kZH ) in the Being Human in the Biotech Age film series is Surviving Eugenics ( http://eugenicsarchive.rsvp1.com/s1900el93kZI ), a just-released documentary about the history and ongoing significance of eugenics in Western Canada. The screening and discussion with filmmakers Rob Wilson and Nicola Fairbrother (joining us via video) takes place Tuesday, November 17, 4pm, 470 Stephens Hall, UC Berkeley. Biotechnologies and Immigration: Biological Citizenship and the Use of DNA Testing for Family Reunification: Torsten Heinemann, Professor of Sociology, University of Hamburg will discuss ( https://facebook.rsvp1.com/s1928el93kZO ) an international research project on the use of DNA testing for family reunification in Europe and compare the situation in the US. Please join us on Tuesday, October 20, noon-1:30pm, 2538 Channing Way, Berkeley. The CRISPR Germline Debate: Closed to the Public? ( http://www.geneticsandsociety.rsvp1.com/s19a0el93kZQ ) by Elliot Hosman Recent CRISPR media coverage focuses on hype rather than engaging the ethical and social implications of the groundbreaking technology—even as many call for public inclusion in the genome editing debate. CRISPR-Cpf1: Hype by Association ( http://www.geneticsandsociety.rsvp1.com/s15b8fl93kZS ) by Elliot Hosman Amid Nobel Prize predictions for CRISPR-Cas9 research, a new CRISPR - associated protein takes the media and science community by storm, even as its utility remains unclear. Big Money Heading for Consumer Genomics ( http://www.geneticsandsociety.rsvp1.com/s1590fl93kZU ) by Pete Shanks Investors are now betting hundreds of millions of dollars that the direct-to-consumer testing business will become profitable. Surrogacy as an Iceberg: 90 Percent Below Water ( http://www.geneticsandsociety.rsvp1.com/s19ccel93kZX ) by Emma Maniere While agencies market surrogacy as a fulfilling “journey,” they also caution prospective consumers about ethical and financial pitfalls. These contradictory messages reflect the true complexity of commercial surrogacy. Forgotten Stories of the Eugenic Age #4, Part 2: The Black Stork Rises: Dr. Haiselden’s Celebrity and Public Controversy ( http://www.geneticsandsociety.rsvp1.com/s15d4fl93kZZ ) by Natalie Oveyssi After Baby Bollinger’s death under Dr. Haiselden’s care, letter-writers flooded newspapers with both praise and criticism. Haiselden went on to co-write and star in The Black Stork, a film celebrating eugenic medicine. Video Review: Talking Biopolitics ( http://www.geneticsandsociety.rsvp1.com/s1d391l93l01 ) [cites CGS and CGS fellow Lisa Ikemoto] by Rebecca Dimond, BioNews George Annas spoke with Lisa Ikemoto about his new book on genomic medicine and genetic testing. Scientists Find Gene Editing with CRISPR Hard to Resist ( http://www.geneticsandsociety.rsvp1.com/s11210l93l03 ) [quotes Marcy Darnovsky and Pete Shanks] by Cameron Scott, Healthline CRISPR is so cheap and easy to use, we may be genetically engineering human embryos before we have time to decide if we should. The Messy, Complicated Nature of Assisted Reproductive Technology ( http://www.geneticsandsociety.rsvp1.com/s111d0l93l06 ) [cites CGS's Marcy Darnovsky] by J. Wesley Judd, Pacific Standard A California court ART case shows that even when there is a contract, the issues are far from black and white. List of Speakers for NAS Meeting on Human Gene Editing ( http://www.geneticsandsociety.rsvp1.com/s1d551l93l08 ) by Paul Knoepfler, Knoepfler Lab Stem Cell Blog A preliminary list of speakers for the National Academies' international summit on human gene editing has emerged, showing a troubling lack of diversity. Limits of Responsibility: Genome Editing, Asilomar, and the Politics of Deliberation ( http://www.geneticsandsociety.rsvp1.com/s1eed1l93l0b ) by J. Benjamin Hurlbut, Hastings Center Report What justifies the notion that CRISPR has caught us off guard or that it is appropriate for experts to retreat into secluded spaces to define the parameters of public debate? Designer babies crawl closer ( http://www.geneticsandsociety.rsvp1.com/s12c90l93l0e ) by Laurie Zoloth, Cosmos Magazine Embryo engineering has been rejected by every ethics committee that has ever considered it. After Asilomar ( http://www.geneticsandsociety.rsvp1.com/s1ed11l93l0g ) by Editorial, Nature News Scientist-led conferences are no longer the best way to resolve debates on controversial research, and scientists who wish to self-regulate ignore public outcry at their peril. Where in the world could the first CRISPR baby be born? ( http://www.geneticsandsociety.rsvp1.com/s12990l93l0i ) by Heidi Ledford, Nature News Nature surveys the legal landscape of 12 countries with well-funded biological research and finds variety of bans on human genome editing in research or reproduction. UNESCO Calls for More Regulations on Genome Editing, DTC Genetic Testing ( http://www.geneticsandsociety.rsvp1.com/s12a50l93l0l ) by Staff, GenomeWeb The organization's International Bioethics Committee reaffirms its support for a moratorium on modifying the human germline. Gene-edited 'micropigs' to be sold as pets at Chinese institute ( http://www.geneticsandsociety.rsvp1.com/s1ebd1l93l0n ) by David Cyranoski, Nature News Originally designed as models for testing expensive drugs in smaller quantities, the pigs are now being marketed as customizable pets. New CRISPR Protein Slices through Genomes, Patent Problems ( http://www.geneticsandsociety.rsvp1.com/s1e351l93l0p ) by Antonio Regalado, MIT Technology Review With patent rights and Nobel Prize announcements pending, the Broad Institute's Feng Zhang reports the development of a new CRISPR gene editing enzyme. Genes can’t be patented, rules Australia’s High Court ( http://www.geneticsandsociety.rsvp1.com/s1e211l93l0s ) by Michael Slezak, New Scientist The decision is considered stronger than the similar one by the US Supreme Court. A Tale of Do-It-Yourself Gene Therapy ( http://www.geneticsandsociety.rsvp1.com/s1e091l93l0u ) by Antonio Regalado, MIT Technology Review An American biotech CEO of BioViva claims she is the first to undergo gene therapy to reverse aging, participating in an experiment that intentionally avoided approval processes. Handheld DNA reader revolutionary and democratising, say scientists ( http://www.geneticsandsociety.rsvp1.com/s12110l93l0w ) by Ian Sample, The Guardian The $1,000 device is not designed to read human genomes, but it can quickly identify bacteria and viruses, and spot different gene variants in sections of human genetic code. New Psychiatric DNA Testing Is Unproven Ground ( http://www.geneticsandsociety.rsvp1.com/s1e591l93l0y ) by Susan Donaldson James, NBC News Using genetic testing to determine the best course of psychiatric medications is an unproven proposition that may pose risks to patients' health. Who has your DNA—or wants it ( http://www.geneticsandsociety.rsvp1.com/s136d0l93l0B ) by Jocelyn Kaiser, Science More and more groups are amassing computer server-busting amounts of human DNA. At least 17 biobanks hold, or plan to hold, genomic data on 75,000 or more people. Born that way? ‘Scientific’ racism is creeping back into our thinking. Here’s what to watch out for. ( http://www.geneticsandsociety.rsvp1.com/s13450l93l0D ) by W. Carson Byrd & Matthew W. Hughey, Washington Post Recent studies show the media and white communities embracing the idea of racial genetic differences, twisting history and circumventing effective policy strategies. What 2,500 Sequenced Genomes Say about Humanity’s Future ( http://www.geneticsandsociety.rsvp1.com/s1f5d1l93l0F ) by Lizzie Wade, Wired Genomics has gone from being a "race-free" science to being a "race-positive" one. Gay or Straight? Saliva Test Can Predict Male Sexual Orientation ( http://www.geneticsandsociety.rsvp1.com/s13150l93l0H ) by Jessica Hamzelou, New Scientist Many scientists have expressed caution over the results, and concerns over potential misuse have led the lead researcher to quit the project entirely. No, Scientists Have Not Found the 'Gay Gene' ( http://www.geneticsandsociety.rsvp1.com/s13010l93l0K ) by Ed Yong, The Atlantic A widely reported study purporting to find epigenetic marks associated with sexual orientation in men is an underpowered fishing expedition that used inappropriate statistics. Ancestry.com is talking to the FDA about using DNA to estimate people's risk of disease ( http://www.geneticsandsociety.rsvp1.com/s13290l93l0M ) by Arielle Duhaime-Ross, The Verge After the FDA regulated 23andMe, another big player in the personal genomics business who has focused on genetic ancestry is looking to merge into providing lucrative health information. Can 23andMe have it all? ( http://www.geneticsandsociety.rsvp1.com/s1f311l93l0O ) by Kelly Servick, Science The company has made about 30 deals with biotech and pharma companies, and plans to hire 25 scientists in the next year to begin drug discovery efforts of its own. 'Great Pause' Among Prosecutors As DNA Proves Fallible ( http://www.geneticsandsociety.rsvp1.com/s1fb91l93l0Q ) by Martin Kaste, NPR The revelation that Texas labs have been using outdated protocols to analyze mixed DNA samples has led to concerns about thousands of criminal cases. Advances in DNA Testing Could Put Thousands of Texas Cases in Legal Limbo ( http://www.geneticsandsociety.rsvp1.com/s13a10l93l0S ) by Meagan Flynn, Houston Press Problems with analyses of testing with mixed DNA samples has cast doubt on many DNA-based criminal convictions in Texas. DNA At the Fringes: Twins, Chimerism, and Synthetic DNA ( http://www.geneticsandsociety.rsvp1.com/s13890l93l0U ) by Erin E. Murphy, The Daily Beast DNA tests are thought to be conclusive, but our genetic material acts in mysterious ways. Chimerism, for example, may "undermine the very basis of the forensic DNA system." Prop 47 Could Purge DNA Database ( http://www.geneticsandsociety.rsvp1.com/s1fd51l93l0X ) by Kristina Davis, The San Diego Union-Tribune Sooam Biotech, founded by scientific pariah Hwang Woo Suk, has A California ballot initiative reduced certain low-level, nonviolent felonies to misdemeanors, but the fate of the consequent DNA collection is unclear. DARPA Gives MIT Lab $32 Million to Program Living Cells ( http://www.geneticsandsociety.rsvp1.com/s13cd0l93l0Z ) by Alexandra Ossola, Popular Science The contract will allow synthetic biology and computer scientists to join forces with chemical, pharma, food, energy, agriculture, and biotech companies. What DARPA hopes to gain remains vague. Sky-high price of new stem cell therapies is a growing concern ( http://www.geneticsandsociety.rsvp1.com/s14390l93l11 ) by Michael Hiltzik, Los Angeles Times Late-stage clinical trials of two treatments backed by California's $6-billion stem cell program are underway. Will Californians be able to afford them? First 'in womb' stem cell trial to begin ( http://www.geneticsandsociety.rsvp1.com/s18211l93l13 ) by James Gallagher, BBC A UK clinical trial injecting fetal stem cells into babies still in the womb will attempt to lessen symptoms of an incurable brittle bone diseases. Feminists, get ready: pregnancy and abortion are about to be disrupted ( http://www.geneticsandsociety.rsvp1.com/s181d1l93l16 ) by Eleanor Robertson, The Guardian A clinical trial of uterine transplants will begin soon in the UK. Are artificial wombs on the horizon? UK Womb Transplants: 5 Ethical Issues ( http://www.geneticsandsociety.rsvp1.com/s14550l93l18 ) by Rachael Rettnerr, Live Science The procedure would expose both patient and developing fetus to autoimmune suppressants, use uteruses from deceased donors, and require that clinical patients have a "long-term partner." Womb transplants given UK go-ahead ( http://www.geneticsandsociety.rsvp1.com/s17f90l93l1a ) BBC Ten women will be chosen for a clinical trial that will transplant a donated uterus, monitor organ acceptance for a year, and initiate up to two IVF pregnancies before removing the transplant. Why the Majority of Sperm Donations in Canada Are from the U.S. ( http://www.geneticsandsociety.rsvp1.com/s1be11l93l1c ) [Canada] by Jim Brown, Canadian Broadcasting Corporation Only 5-10% of donated sperm in Canada is from domestic donors; the majority comes from US providers who, unlike their counterparts north of the border, are paid. 30k-60K US Sperm and Egg Donor Births Per Year? ( http://www.geneticsandsociety.rsvp1.com/s1bc91l93l1e ) by Wendy Kramer, Huffington Post For 28 years the estimated number of children born via donor insemination has remained 30,000. But there is no reliable information in the public domain. Informed Consent for Egg Donors Won’t Exist Unless We Track Donors’ Health ( http://www.geneticsandsociety.rsvp1.com/s17950l93l1h ) by Judy E. Stern, Our Bodies, Our Blog Recent academic articles raise concerns that conflicts of interest may result in egg providers having an incomplete understanding of the risks of eggs retrieval procedures. Next-Generation Prenatal Genetic Tests Are Turning Fate Into Choice ( http://www.geneticsandsociety.rsvp1.com/s1b8d1l93l1j ) by Michael White, Pacific Standard The new tests mean that many more women are grappling with the decision of whether to continue or end a pregnancy based on genetic information. Women Find a Fertility Test Isn't as Reliable as They'd Like ( http://www.geneticsandsociety.rsvp1.com/s1ba51l93l1l ) by Eliza Barclay, NPR Ovarian reserve tests are often ambiguous and can be misinterpreted; some fertility specialists worry that many women will be misled by their results. What's Missing From Ontario's IVF Policy? ( http://www.geneticsandsociety.rsvp1.com/s17bd0l93l1n ) by Vanessa Gruben, Ottawa Citizen The province should require collection of anonymized data on IVF use, success rates, and complications; it should also address the information needs of children conceived via donor gametes. Ontario to Cover In-Vitro Fertilization Treatments ( http://www.geneticsandsociety.rsvp1.com/s17350l93l1p ) [Canada] by Rob Ferguson, The Star Ontario has become the second Canadian province to cover some of the costs of IVF. Why Some Parents Choose to Have a Deaf Baby ( http://www.geneticsandsociety.rsvp1.com/s17210l93l1s ) by Rich Wordsworthn, Motherboard Some deaf parents ask, "What’s wrong with being deaf, anyway? I’m happy to be who I am." Disgraced Scientist Clones Dogs, and Critics Question His Intent ( http://www.geneticsandsociety.rsvp1.com/s17090l93l1u ) by Rob Stein, NPR Sooam Biotech, founded by scientific pariah Hwang Woo Suk, has cloned over 600 dogs for $100,000 each. The process works only one-third of the time and is risky. [Australia] Stem cell experts urge ethical debate over embryo creation ( http://www.geneticsandsociety.rsvp1.com/s1b111l93l1w ) by Anna Salleh, ABC Science Scientists pursuing basic research with pluripotent stem cells may be able to grow a cell structure that would resembles a three- to four-week embryo within just a couple of years. GMO Propaganda and the Sociology of Science ( http://www.geneticsandsociety.rsvp1.com/s17590l93l1y ) by Kristine Mattis, Counterpunch The false association between anti-GMO and anti-science sentiment obscures the lack of scientific consensus about the health and environmental effects of genetically modified crops. Who has your DNA—or wants it ( http://www.geneticsandsociety.rsvp1.com/s1a6d1l93l1B ) by Jocelyn Kaiser, Science More and more groups are amassing computer server–busting amounts of human DNA. At least 17 biobanks hold, or plan to hold, genomic data on 75,000 or more people. Can 23andMe have it all? ( http://www.geneticsandsociety.rsvp1.com/s1a451l93l1D ) by Kelly Servick, Science The company has made about 30 deals with biotech and pharma companies, and plans to hire 25 scientists in the next year to begin drug discovery efforts of its own. New CRISPR Protein Slices through Genomes, Patent Problems ( http://www.geneticsandsociety.rsvp1.com/s165d0l93l1F ) by Antonio Regalado, MIT Technology Review With patent rights and Nobel Prize announcements pending, the Broad Institute's Feng Zhang reports the development of a new CRISPR gene editing enzyme. ( https://networkforgood.rsvp1.com/s1a151l93l1H ) ------------------------- This e-mail was sent to [email protected] by [email protected]. Center for Genetics & Society, 1936 University Ave., Suite 350, Berkeley, California 94704 If you no longer wish to receive commercial e-mail messages from [email protected], please select the following link: Remove ( https://salesgenius.rsvp1.com/s18d10l93l2g ).